Novo Nordisk Cuts Wegovy Prices

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.

Novo Nordisk is lowering prices for its weight-loss drug, Wegovy. Patients can now pay less, for example, $349 a month for higher doses.

Doctors say the new prices are still too high for many patients. Eli Lilly also plans to reduce prices for its similar drug, Zepbound.

These drugs are popular and help people lose a lot of weight. They work by changing how the body handles hunger and fullness.

Paying for these medicines is still a big problem for many. Many people find it hard to afford these important treatments.

Medicare will start to cover these drugs for some people next year. This change will help more Americans get access to these medicines.

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What is the name of the weight-loss drug that Novo Nordisk is lowering prices for?

The name of the weight-loss drug is Wegovy.

What is the new monthly price for higher doses of Wegovy?

The new monthly price for higher doses of Wegovy is $349.

What will Medicare do next year regarding these drugs?

Medicare will start to cover these drugs for some people next year.

Look at the article image and describe what you see on it. You may either speak or write your answer there.

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com